Lantheus Holdings, Inc. Deferred Tax Liabilities, Gross
Lantheus Holdings, Inc. (LNTH) had Deferred Tax Liabilities, Gross of $100.05 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-26
- 2025-12-31: Deferred Tax Liabilities, Gross $100.05M.
- 2024-12-31: Deferred Tax Liabilities, Gross $19.12M.
- 2023-12-31: Deferred Tax Liabilities, Gross $11.54M.
- 2022-12-31: Deferred Tax Liabilities, Gross $87.98M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $100.05M 10-K · filed 2026-02-26 |
| 2024-12-31 | $19.12M 10-K · filed 2026-02-26 |
| 2023-12-31 | $11.54M 10-K · filed 2025-02-26 |
| 2022-12-31 | $87.98M 10-K · filed 2024-02-22 |
| 2021-12-31 | $90.38M 10-K · filed 2023-02-23 |
| 2020-12-31 | $96.96M 10-K · filed 2022-02-24 |
| 2019-12-31 | $1.59M 10-K · filed 2021-02-25 |
| 2018-12-31 | $2.79M 10-K · filed 2020-02-25 |
| 2017-12-31 | $2.64M 10-K · filed 2019-02-20 |
| 2016-12-31 | $3.69M 10-K · filed 2018-02-26 |
| 2015-12-31 | $4.96M 10-K · filed 2017-02-23 |
| 2014-12-31 | $6.75M 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |